Polybutadiene Market Anticipated to Witness High Growth Owing to Rising Applications in Tires and Rubber Industry

 

Polybutadiene Market

Polybutadiene, commonly known as butadiene rubber or BR, is a synthetic rubber produced from butadiene. It is known for its excellent flexibility, tensile strength and resistance to abrasion. Polybutadiene finds extensive applications as a raw material in tire and rubber products manufacturing. Its low rolling resistance and high traction properties make it suitable for tire treads. Other key applications of polybutadiene include hoses, belts, gaskets and footwear.

 

The Global Polybutadiene Market is estimated to be valued at US$ 6.23 Bn in 2024 and is expected to exhibit a CAGR of 8.8% over the forecast period 2024 to 2030.

Rising automotive production along with growing demand for affordable and fuel-efficient tires is a major growth driver for polybutadiene demand. Replacement of aging vehicles also supports market growth.

 

Key Takeaways

Key players operating in the Global Polybutadiene Market Size are Envista Holdings Corporation, Planmeca Oy, Acteon Group, DENTSPLY Sirona, Carestream Dental, VATECH Co. Ltd., Owandy Radiology, Durr Dental SE, Midmark Corporation, Genoray Co. Ltd., Asahi Roentgen Co. Ltd., 3Shape, PreXion Inc., Cefla Medical Equipment, Apteryx Imaging (Canada), Yoshida Dental Mfg. Co. Ltd, and Align Technology Inc.

 

The polybutadiene market offers significant growth opportunities particularly in developing economies experiencing rapid automobile production and sales growth in Asia Pacific and Latin America. Key market players are investing in capacity expansions to tap the potential offered by emerging markets.

 

Global polybutadiene demand is expanding as major market players pursue geographic and capacity expansion strategies. Manufacturers are setting up new production facilities worldwide to meet the rising demand from international rubber product manufacturers.

 

Market drivers:

- Growing automobile production and sales, particularly in developing nations owing to rising disposable incomes and economic growth. Tires remain a key end-use sector for polybutadiene.

- Replacement demand for aging vehicles fleet helps sustain polybutadiene consumption over the long term.

 

Market restraints:

- Increased preference for fuel-efficient and eco-friendly materials like silica in tire manufacturing limits polybutadiene use to some extent.

- Volatility in crude oil and butadiene prices poses risks to stable polybutadiene supply and manufacturing costs.

 

Segment Analysis

The polybutadiene market is dominated by the styrenic segment which accounts for over 50% of the total market share. Styrenic polybutadiene is useful for manufacturing tires as it imparts good wear resistance, traction and low rolling resistance properties. These special characteristic makes them preferred in the tire industry.

 

Global Analysis

The Asia Pacific region dominates the global polybutadiene market and accounted for over 45% of the total market share in 2024. China is the largest producer and consumer of polybutadiene owing to large scale tire manufacturing in the country. The demand for polybutadiene is expected to grow rapidly in Asia Pacific due to increasing automotive sales driven by emerging economies like India and Indonesia. North America is another major market for polybutadiene owing to stable demand from the tire industry. Stringent environmental regulations regarding fuel efficiency and low rolling resistance in countries like the US and Canada drives the polybutadiene consumption.

Get More Insights Here

https://www.newsanalyticspro.com/polybutadiene-market-size-share-growth-outlook-2023/

Comments

Post a Comment

Popular posts from this blog

"Global Heparin Market: Current Trends and Future Prospects"

Image
  Heparin, a crucial anticoagulant, has been a mainstay in the pharmaceutical industry for many years. It plays a pivotal role in preventing and treating conditions such as deep vein thrombosis, pulmonary embolism, and various cardiovascular diseases. As we delve into the current state of the heparin market, we will explore the trends, challenges, and opportunities that shape this vital segment of the pharmaceutical industry. Market Overview: The global heparin market has experienced steady growth over the years, driven by an aging population, increasing cases of cardiovascular diseases, and a rising awareness of the importance of anticoagulants in healthcare. Heparin is available in various forms, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH), each with its own set of applications and market dynamics. Trends: 1.      Rising Demand for LMWH : Low molecular weight heparin is gaining popularity due to its ease of administr...
Read more

"Advancements in Cystic Fibrosis Treatment: A Comprehensive Market Analysis"

Image
  The cystic fibrosis market has seen significant advancements and changes in recent years. Cystic fibrosis is a genetic disorder that affects the lungs and digestive system, leading to thick and sticky mucus production that can cause serious respiratory and digestive complications. The introduction of new therapies and treatments, such as CFTR modulators, has revolutionized the management of cystic fibrosis, offering hope and improved quality of life for patients. These drugs target the underlying genetic mutations responsible for the condition, helping to alleviate symptoms and slow disease progression. However, challenges remain in the cystic fibrosis market . Access to these ground-breaking therapies can be limited due to high costs, and ongoing research is needed to develop treatments for all genetic mutations associated with the disease. Additionally, the market continues to evolve as new therapies and innovations emerge. Collaborative efforts between pharmaceutical compani...
Read more

"Advancements in Thyroid Cancer Drugs Market: A Comprehensive Analysis"

Image
  Thyroid cancer is a relatively rare but potentially life-threatening condition that affects the thyroid gland. It has been on the radar of medical researchers and pharmaceutical companies for quite some time, leading to significant advancements in the development of thyroid cancer drugs. In this blog, we will explore the latest developments in the thyroid cancer drugs market and how they are shaping the landscape of treatment options for thyroid cancer patients. 1.      Targeted Therapies: One of the most notable advancements in thyroid cancer treatment is the emergence of targeted therapies. These drugs are designed to specifically target cancer cells, sparing healthy cells and reducing side effects. Some targeted therapies approved for thyroid cancer include Sorafenib and Lenvatinib, which have shown promise in slowing down tumor growth and improving patient outcomes. 2.      Immunotherapy: Immunotherapy has gained significant at...
Read more